Colorectal Cancer Clinical Trials in Chicago

Showing 301-320 of 348 trials

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

NCT01260168

The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.

Colorectal NeoplasmsDigestive System DiseasesColonic Diseases+1 more

Exact Sciences Corporation435 participantsStarted Oct 2010

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Atlanta, Georgia, United States +18 more locations

COMPLETEDNA2.2 miles

Low Literacy Intervention for Colorectal Cancer Screening

NCT00012922

Of 17 performance measures of hospital quality regularly reported for the Veterans Administration (VA) health care system, rates of colorectal cancer screening are the lowest.

Colorectal Cancer

US Department of Veterans Affairs2,400 participants

Chicago, Illinois, United States

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Low Literacy Intervention for Colorectal Cancer Screening

Colorectal Cancer Trials in Other Cities

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

Study of In-home Tests for Colorectal Cancer

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy

Other Conditions in Chicago